ExoticRx · exoticrx.com/drugs/ranolazine
Ranexa
Inhibits late inward sodium current (INaL) during cardiac repolarization, reducing intracellular sodium and calcium overload.
QT prolongation risk. Avoid with strong CYP3A inhibitors. Limited veterinary data — investigational use.
Species references:All Cat (Domestic) drugsAll Dog (Domestic) drugs
Each ExoticRx dose rule is graded by the strength of its primary evidence — see the editorial process.
A dog/cat sample is shown here. Cited dosing for all 2 species — reptiles, birds, pocket pets, livestock, and equine — is free on the per-species pages above. Pro adds the weight-based calculator for every species.
| Species | Route | Dose | Frequency | Evidence | Source |
|---|---|---|---|---|---|
| Dog (Domestic) | PO | 5–15 mg/kg | q12h | Weak | Veterinary Cardiology Literature Review |
| Cat (Domestic) | PO | 5–10 mg/kg | q12h | Extrapolated | Veterinary Cardiology Literature Review |
Upgrade to Pro or Student to unlock the full dose ranges and frequency for every species. The drug's mechanism, warnings, indications, and cited sources are free to read.
View PlansSource citations and evidence levels available on the live page. Reference only — verify against current literature before clinical use.